Anna-Liisa Nieminen

Dr. Anna-Liisa Nieminen

Department of Drug Discovery and Biomedical Sciences, Center for Cell Death, Injury and Regeneration, Medical University of South Carolina, Charleston, SC, USA
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
HHHsin-I Hung
Hsin-I Hung
JSJustin M. Schwartz
Justin M. Schwartz
EMEduardo N. Maldonado
Eduardo N. Maldonado
JLJohn J. Lemasters
John J. Lemasters
Anna-Liisa NieminenAnna-Liisa Nieminen
Anna-Liisa Nieminen
Photodynamic therapy (PDT) is a promising approach to treat head and neck cancer cells. Here, we investigated whether mitochondrial iron uptake through mitoferrin-2 (Mfrn2) enhanced PDT-induced cell killing. Three human head and neck squamous carcinoma cell lines (UMSCC1, UMSCC14A, and UMSCC22A) were exposed to light and Pc 4, a mitochondria-targeted photosensitizer. The three cell lines responded differently: UMSCC1 and UMSCC14A cells were more resistant, whereas UMSCC22A cells were more sensitive to Pc 4-PDT-induced cell death. In non-erythroid cells, Mfrn2 is an iron transporter in the mitochondrial inner membrane. PDT-sensitive cells expressed higher Mfrn2 mRNA and protein levels compared with PDT-resistant cells. High Mfrn2-expressing cells showed higher rates of mitochondrial Fe2+ uptake compared with low Mfrn2-expressing cells. Bafilomycin, an inhibitor of the vacuolar proton pump of lysosomes and endosomes that causes lysosomal iron release to the cytosol, enhanced PDT-induced cell killing of both resistant and sensitive cells. Iron chelators and the inhibitor of the mitochondrial Ca2+ (and Fe2+) uniporter, Ru360, protected against PDT plus bafilomycin toxicity. Knockdown of Mfrn2 in UMSCC22A cells decreased the rate of mitochondrial Fe2+ uptake and delayed PDT plus bafilomycin-induced mitochondrial depolarization and cell killing. Taken together, the data suggest that lysosomal iron release and Mfrn2-dependent mitochondrial iron uptake act synergistically to induce PDT-mediated and iron-dependent mitochondrial dysfunction and subsequent cell killing. Furthermore, Mfrn2 represents a possible biomarker of sensitivity of head and neck cancers to cell killing after PDT.

1 September 2014 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
SQSuparna Qanungo
Suparna Qanungo
JUJoachim D. Uys
Joachim D. Uys
YMYefim Manevich
Yefim Manevich
ADAnne M. Distler
Anne M. Distler
BSBrooke Shaner
Brooke Shaner
Anna-Liisa NieminenAnna-Liisa Nieminen
Anna-Liisa Nieminen

5 January 2012 in Photochemistry and Photobiology
Verified
Journal Article
Closed access
PDF file
SSShalini Saggu
Shalini Saggu
HHHsin‐I Hung
Hsin‐I Hung
GQGeraldine Quiogue
Geraldine Quiogue
JLJohn J. Lemasters
John J. Lemasters
Anna-Liisa NieminenAnna-Liisa Nieminen
Anna-Liisa Nieminen

30 July 2024 in Livers
Verified
Journal Article
Open access
PDF file
JHJiangting Hu
Jiangting Hu
Anna-Liisa NieminenAnna-Liisa Nieminen
Anna-Liisa Nieminen
ZZZhi Zhong
Zhi Zhong
JLJohn J. Lemasters
John J. Lemasters
Overdose of acetaminophen (APAP) produces fulminant hepatic necrosis. The underlying mechanism of APAP hepatotoxicity involves mitochondrial dysfunction, including mitochondrial oxidant stress and the onset of mitochondrial permeability transition (MPT). Reactive oxygen species (ROS) play an important role in APAP-induced hepatotoxicity, and iron is a critical catalyst for ROS formation. This review summarizes the role of mitochondrial ROS formation in APAP hepatotoxicity and further focuses on the role of iron. Normally, hepatocytes take up Fe3+-transferrin bound to transferrin receptors via endocytosis. Concentrated into lysosomes, the controlled release of iron is required for the mitochondrial biosynthesis of heme and non-heme iron-sulfur clusters. After APAP overdose, the toxic metabolite, NAPQI, damages lysosomes, causing excess iron release and the mitochondrial uptake of Fe2+ by the mitochondrial calcium uniporter (MCU). NAPQI also inhibits mitochondrial respiration to promote ROS formation, including H2O2, with which Fe2+ reacts to form highly reactive •OH through the Fenton reaction. •OH, in turn, causes lipid peroxidation, the formation of toxic aldehydes, induction of the MPT, and ultimately, cell death. Fe2+ also facilitates protein nitration. Targeting pathways of mitochondrial iron movement and consequent iron-dependent mitochondrial ROS formation is a promising strategy to intervene against APAP hepatotoxicity in a clinical setting.

29 June 2009
Verified
Conference Paper
Closed access
PDF file
GQGeraldine Quiogue
Geraldine Quiogue
SSShalini Saggu
Shalini Saggu
HHHsin-I Hung
Hsin-I Hung
MKMalcolm E. Kenney
Malcolm E. Kenney
NONancy L. Oleinick
Nancy L. Oleinick
Anna-Liisa NieminenAnna-Liisa Nieminen
Anna-Liisa Nieminen
In photodynamic therapy (PDT), visible light activates a photosensitizing drug added to a tissue, resulting in singlet oxygen formation and cell death. Assessed by confocal microscopy, the photosensitizer phthalocyanine 4 (Pc 4) localizes primarily to mitochondrial membranes in cancer cells, resulting in mitochondria-mediated cell death. A Pc 4 derivative, Pc 181, accumulates into lysosomes. In comparison to Pc 4, Pc 181 was a more effective photosensitizer promoting killing cancer cells after PDT. The mode of cell death after Pc 181-PDT is predominantly apoptosis, and pancaspase and caspase-3 inhibitors prevent onset of the cell death. To assess further how lysosomes contribute to PDT, we monitored cell killing of A431cells after PDT in the presence and absence of bafilomycin, an inhibitor of the acidic vacuolar proton pump that collapses the pH gradient of the lysosomal/endosomal compartment. Bafilomycin by itself did not induce toxicity but greatly enhanced Pc 4-PDT-induced cell killing. In comparison to Pc 4, less enhancement of cell killing by bafilomycin occurred after Pc 181-PDT at photosensitizer doses producing equivalent cell killing in the absence of bafilomycin. These results indicate that lysosomal disruption can augment PDT with Pc 4, which targets predominantly mitochondria, but less so after PDT with Pc 181, since Pc 181 already targets lysosomes.

1 July 2014 in Biochimica et Biophysica Acta (BBA) - Bioenergetics
Verified
Journal Article
Closed access
Anna-Liisa NieminenAnna-Liisa Nieminen
Anna-Liisa Nieminen
JSJustin M. Schwartz
Justin M. Schwartz
HHHsin-I Hung
Hsin-I Hung
EBE. Riley Blocker
E. Riley Blocker
MGMonika Gooz
Monika Gooz
JLJohn J. Lemasters
John J. Lemasters